SK Biopharm Signs Pharmaceutical Supply Contract Worth 28.8 Billion KRW
[Asia Economy Reporter Minji Lee] SK Biopharm announced on the 20th that it has signed a pharmaceutical supply contract worth 28,860,100,000 KRW with SK Life Science. This amounts to 110% of its recent sales revenue.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- Rape Case from 17 Years Ago... Man in His 40s Identified by DNA Has Sentence Reduced on Appeal
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
